ATM FUNCTION DURING V(D)J RECOMBINATION

V(D)J 重组期间的 ATM 功能

基本信息

  • 批准号:
    7742978
  • 负责人:
  • 金额:
    $ 37.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-12-02 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mutations in the gene encoding the ATM serine-threonine kinase cause Ataxia Telangiectasia (A-T), a disease marked by lymphopenia and an increased incidence of lymphoid tumors with translocations involving antigen receptor loci, suggesting that ATM functions during V(D)J recombination. ATM activates cell cycle checkpoints in response to DNA double strand breaks (DSBs). However, the lymphoid phenotypes of A-T are not recapitulated in mice with isolated deficiencies in checkpoint pathways. We have demonstrated that ATM functions to repair DSBs generated during V(D)J recombination, and to suppress the aberrant resolution of these DSBs as chromosomal translocations. The combined defect in checkpoint pathways and DSB repair explains some of the lymphoid phenotypes of A-T. Given all of the defects in V(D)J recombination observed in ATM-deficient lymphocytes, we have proposed that ATM functions, in part, to maintain the stability of DSB complexes after RAG-mediated DNA cleavage, which is a hypothesis that will be directly tested in Specific Aim One. Although ATM could function directly in the repair of RAG-mediated DSBs, we expect that ATM will likely phosphorylate proteins that perform this function. In this regard we show that the MRN complex (Mre11, Rad50 and Nbs1), 53BP1 and H2AX, which are all targets of ATM, function in the response to RAG-mediated DSBs. How these proteins function in the ATM-dependent pathway of RAG-DSB repair will be elucidated in Specific Aim Two. In addition, we will consider the possibility that the RAG proteins may have ATM-dependent functions in the joining step of the V(D)J recombination reaction. Importantly, we believe that these different proteins will function in an integrated manner in the ATM-dependent RAG-DSB repair pathway. Finally, we will investigate the mechanisms by which DNA DSBs generated during V(D)J recombination in ATM-deficient cells become aberrantly resolved as chromosomal translocations (Specific Aim 3). The completion of these aims will provide important new information about: 1) how RAG-mediated DSBs are repaired; 2) how ATM functions in DSB repair and in maintaining genomic stability; and 3) the mechanisms that promote the formation of chromosomal translocations. PUBLIC HEALTH RELEVANCE: The ataxia telangiectasia mutated (ATM) protein is a critical initiator of DNA damage responses. We have shown that ATM is also involved in the repair of RAG-mediated DSBs generated during lymphocyte antigen receptor gene assembly. Here we propose to identify the proteins in the ATM-dependent pathway of RAG- DSB repair and determine how they function. Furthermore, we will elucidate the mechanisms that lead to the frequent aberrant resolution of DNA breaks as chromosomal translocations in ATM-deficient cells.
DESCRIPTION (provided by applicant): Mutations in the gene encoding the ATM serine-threonine kinase cause Ataxia Telangiectasia (A-T), a disease marked by lymphopenia and an increased incidence of lymphoid tumors with translocations involving antigen receptor loci, suggesting that ATM functions during V(D)J recombination. ATM activates cell cycle checkpoints in response to DNA double strand breaks (DSBs). However, the lymphoid phenotypes of A-T are not recapitulated in mice with isolated deficiencies in checkpoint pathways. We have demonstrated that ATM functions to repair DSBs generated during V(D)J recombination, and to suppress the aberrant resolution of these DSBs as chromosomal translocations. The combined defect in checkpoint pathways and DSB repair explains some of the lymphoid phenotypes of A-T. Given all of the defects in V(D)J recombination observed in ATM-deficient lymphocytes, we have proposed that ATM functions, in part, to maintain the stability of DSB complexes after RAG-mediated DNA cleavage, which is a hypothesis that will be directly tested in Specific Aim One. Although ATM could function directly in the repair of RAG-mediated DSBs, we expect that ATM will likely phosphorylate proteins that perform this function. In this regard we show that the MRN complex (Mre11, Rad50 and Nbs1), 53BP1 and H2AX, which are all targets of ATM, function in the response to RAG-mediated DSBs. How these proteins function in the ATM-dependent pathway of RAG-DSB repair will be elucidated in Specific Aim Two. In addition, we will consider the possibility that the RAG proteins may have ATM-dependent functions in the joining step of the V(D)J recombination reaction. Importantly, we believe that these different proteins will function in an integrated manner in the ATM-dependent RAG-DSB repair pathway. Finally, we will investigate the mechanisms by which DNA DSBs generated during V(D)J recombination in ATM-deficient cells become aberrantly resolved as chromosomal translocations (Specific Aim 3). The completion of these aims will provide important new information about: 1) how RAG-mediated DSBs are repaired; 2) how ATM functions in DSB repair and in maintaining genomic stability; and 3) the mechanisms that promote the formation of chromosomal translocations. PUBLIC HEALTH RELEVANCE: The ataxia telangiectasia mutated (ATM) protein is a critical initiator of DNA damage responses. We have shown that ATM is also involved in the repair of RAG-mediated DSBs generated during lymphocyte antigen receptor gene assembly. Here we propose to identify the proteins in the ATM-dependent pathway of RAG- DSB repair and determine how they function. Furthermore, we will elucidate the mechanisms that lead to the frequent aberrant resolution of DNA breaks as chromosomal translocations in ATM-deficient cells.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BARRY P SLECKMAN其他文献

BARRY P SLECKMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BARRY P SLECKMAN', 18)}}的其他基金

INHIBITORS OF COMPENSATORY NHEJ PATHWAYS
NHEJ 代偿途径的抑制剂
  • 批准号:
    8486208
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM FUNCTION DURING V(D)J RECOMBINATION
V(D)J 重组期间的 ATM 功能
  • 批准号:
    7879173
  • 财政年份:
    2009
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM FUNCTION DURING V(D)J RECOMBINATION
V(D)J 重组期间的 ATM 功能
  • 批准号:
    8271430
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM FUNCTION DURING V(D)J RECOMBINATION
V(D)J 重组期间的 ATM 功能
  • 批准号:
    8635819
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM FUNCTION DURING V(D)J RECOMBINATION
V(D)J 重组期间的 ATM 功能
  • 批准号:
    8774161
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM Function During V(D)J Recombination
V(D)J 重组期间的 ATM 功能
  • 批准号:
    10317289
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM Function During V(D)J Recombination
V(D)J 重组期间的 ATM 功能
  • 批准号:
    10307563
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM FUNCTION DURING V(D)J RECOMBINATION
V(D)J 重组期间的 ATM 功能
  • 批准号:
    10062842
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM FUNCTION DURING V(D)J RECOMBINATION
V(D)J 重组期间的 ATM 功能
  • 批准号:
    9180672
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
ATM FUNCTION DURING V(D)J RECOMBINATION
V(D)J 重组期间的 ATM 功能
  • 批准号:
    7578691
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:

相似海外基金

Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
  • 批准号:
    10607414
  • 财政年份:
    2023
  • 资助金额:
    $ 37.62万
  • 项目类别:
Rotation 1: Role of DNA damage in neurodegenerative disease (ataxia telangiectasia)
第 1 轮:DNA 损伤在神经退行性疾病(毛细血管扩张性共济失调)中的作用
  • 批准号:
    2887727
  • 财政年份:
    2023
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Studentship
Ataxia-Telangiectasia: An emerging role for inflammation in driving neurodegeneration and premature ageing
共济失调-毛细血管扩张:炎症在驱动神经退行性变和过早衰老中的新作用
  • 批准号:
    nhmrc : 2001408
  • 财政年份:
    2021
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Ideas Grants
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease
共济失调毛细血管扩张突变 (ATM) 介导的儿童非酒精性脂肪性肝病中的肝 DNA 损伤
  • 批准号:
    10301928
  • 财政年份:
    2021
  • 资助金额:
    $ 37.62万
  • 项目类别:
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease
共济失调毛细血管扩张突变 (ATM) 介导的儿童非酒精性脂肪性肝病中的肝 DNA 损伤
  • 批准号:
    10674036
  • 财政年份:
    2021
  • 资助金额:
    $ 37.62万
  • 项目类别:
Molecular Mechanisms of Purkinje Cell Degeneration in Ataxia-Telangiectasia
共济失调毛细血管扩张症浦肯野细胞变性的分子机制
  • 批准号:
    10193587
  • 财政年份:
    2021
  • 资助金额:
    $ 37.62万
  • 项目类别:
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease
共济失调毛细血管扩张突变 (ATM) 介导的儿童非酒精性脂肪性肝病中的肝 DNA 损伤
  • 批准号:
    10475172
  • 财政年份:
    2021
  • 资助金额:
    $ 37.62万
  • 项目类别:
Defective repair of neuronal activity-induced DNA double strand breaks: A novel pathogenic mechanism for neurodegeneration in ataxia-telangiectasia
神经元活动诱导的 DNA 双链断裂的缺陷修复:共济失调毛细血管扩张神经变性的新致病机制
  • 批准号:
    nhmrc : 1144806
  • 财政年份:
    2018
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Project Grants
Defective repair of neuronal activity-induced DNA double strand breaks: A novel pathogenic mechanism for neurodegeneration in ataxia-telangiectasia
神经元活动诱导的 DNA 双链断裂的缺陷修复:共济失调毛细血管扩张神经变性的新致病机制
  • 批准号:
    nhmrc : GNT1144806
  • 财政年份:
    2018
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Project Grants
Mechanisms of mitochondrial damage in ataxia-telangiectasia
共济失调毛细血管扩张症线粒体损伤的机制
  • 批准号:
    9105821
  • 财政年份:
    2015
  • 资助金额:
    $ 37.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了